1. Tracheoinnominate Fistula: Acute Bleeding and Hypovolemic Shock Due to a Trachea-Innominate Artery Fistula After Long-Term Tracheostomy, Treated With a Stent-Graft
- Author
-
Hans Henkes, Christoph Harmening, Victoria Hellstern, Helfried Meißner, Ali Khanafer, and Klaus Schneider
- Subjects
lcsh:Diseases of the circulatory (Cardiovascular) system ,medicine.medical_specialty ,medicine.medical_treatment ,Fistula ,Medizin ,Case Report ,030204 cardiovascular system & hematology ,030218 nuclear medicine & medical imaging ,03 medical and health sciences ,Tracheostomy ,0302 clinical medicine ,medicine ,Radiology, Nuclear Medicine and imaging ,Stent-graft ,cardiovascular diseases ,medicine.diagnostic_test ,business.industry ,Stent ,Interventional radiology ,medicine.disease ,Cannula ,Tracheoinnominate fistula ,Surgery ,medicine.anatomical_structure ,surgical procedures, operative ,lcsh:RC666-701 ,Eptifibatide ,Cardiology and Cardiovascular Medicine ,Complication ,business ,Ticagrelor ,medicine.drug ,Artery - Abstract
Background A tracheo-innominate fistula is a rare but life-threatening complication of tracheostomy and has a mortality rate of 100% without therapy. The underlying cause is an acquired fistula between the brachiocephalic trunk and the trachea, induced by a tracheostomy cannula’s mechanical impact. Case presentation A 25-year-old female was admitted with pulsatile bleeding from a tracheostomy. The cause of the bleeding was a tracheo-innominate artery fistula, which was difficult to recognize. Said fistula was treated with implantation of a self-expanding stent-graft. The bleeding stopped immediately after the implantation of the stent-graft. Dual antiplatelet medication with aspirin IV and ticagrelor PO, bridged with a bolus of eptifibatide IV, was started right after the stent deployment. Conclusions Endovascular self-expanding stent-graft implantation is a viable treatment option for tracheo-innominate artery fistulae, especially in hemorrhagic emergencies.
- Published
- 2021